BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $103,000 | +21.2% | 30,452 | +3.9% | 0.00% | – |
| Q4 2018 | $85,000 | -55.0% | 29,302 | -4.3% | 0.00% | – |
| Q3 2018 | $189,000 | -21.9% | 30,610 | -6.7% | 0.00% | – |
| Q2 2018 | $242,000 | +63.5% | 32,795 | +44.7% | 0.00% | – |
| Q1 2018 | $148,000 | -24.1% | 22,661 | -2.1% | 0.00% | – |
| Q4 2017 | $195,000 | -25.9% | 23,157 | +1.6% | 0.00% | – |
| Q3 2017 | $263,000 | +0.8% | 22,786 | +2.1% | 0.00% | – |
| Q2 2017 | $261,000 | +19.7% | 22,319 | +26.6% | 0.00% | – |
| Q1 2017 | $218,000 | +1.9% | 17,635 | +12.4% | 0.00% | – |
| Q4 2016 | $214,000 | -24.9% | 15,684 | +9.4% | 0.00% | – |
| Q3 2016 | $285,000 | +77.0% | 14,330 | +15.2% | 0.00% | – |
| Q2 2016 | $161,000 | +312.8% | 12,441 | +178.3% | 0.00% | – |
| Q1 2016 | $39,000 | -60.6% | 4,471 | -8.9% | 0.00% | – |
| Q4 2015 | $99,000 | +6.5% | 4,910 | -23.1% | 0.00% | – |
| Q3 2015 | $93,000 | -31.6% | 6,389 | 0.0% | 0.00% | – |
| Q2 2015 | $136,000 | – | 6,389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|